☆ 4.7 Review

Benefits and Challenges of Treat-to-Target in Inflammatory Bowel Disease

JOURNAL OF CLINICAL MEDICINE (2023)

Related references

Note: Only part of the references are listed.

Article Gastroenterology & Hepatology

Prognostic Value of Fecal Calprotectin to Inform Treat-to-Target Monitoring in Ulcerative Colitis

Parambir S. Dulai et al.

Summary: This study evaluated the value of post-induction fecal calprotectin (FCP) concentration as a biomarker in patients with ulcerative colitis (UC) treated with a biologic. It found that a post-induction FCP concentration of 250 mg/g vs >250 mg/g was associated with an increased probability of achieving long-term clinical, endoscopic, and histologic remission, and a reduced probability of colectomy and UC-related hospitalization.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Add to Collection

Review Medicine, General & Internal

Diagnostic Accuracy of Fecal Calprotectin for Predicting Relapse in Inflammatory Bowel Disease: A Meta-Analysis

Jin-Tong Shi et al.

Summary: Fecal calprotectin (FC) levels are correlated with the disease activity of inflammatory bowel diseases (IBD), but its usefulness in predicting IBD relapse is yet to be determined. This study aimed to evaluate the efficacy of FC in predicting IBD relapse. A total of 24 prospective studies were included in the meta-analysis, and the optimal FC cut-off value was found to be 152 μg/g. The pooled sensitivity and specificity of FC were 0.720 (0.528 to 0.856) and 0.740 (0.618 to 0.834), respectively. FC is a valuable non-invasive and cost-effective biomarker for early prediction of IBD relapse, with an ideal threshold of 152 μg/g.

JOURNAL OF CLINICAL MEDICINE (2023)

Add to Collection

Review Gastroenterology & Hepatology

Management of inflammatory bowel diseases in older adults

Siddharth Singh et al.

Summary: The burden of IBD in older adults is increasing due to an ageing population and the increasing incidence of elderly-onset IBD. However, there is a lack of evidence-based management for older adults with IBD, resulting in variability in care. This population is underrepresented in clinical trials and experiences high rates of corticosteroid use and unplanned healthcare use. A better understanding of biological and functional age, risk assessment tools, and comparative effectiveness of therapies is needed to improve outcomes in older adults with IBD.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2023)

Add to Collection

Article Gastroenterology & Hepatology

How achievable are STRIDE-II treatment targets in real-world practice and do they predict long-term treatment outcomes?

Susanna Meade et al.

Summary: The study evaluated the feasibility of using SES-CD as a treatment target for Crohn's disease, and found that achieving the set endpoints was associated with reduced rates of treatment failure.

FRONTLINE GASTROENTEROLOGY (2023)

Add to Collection

Review Gastroenterology & Hepatology

Treatment escalation and de-escalation decisions in Crohn's disease: Delphi consensus recommendations from Japan, 2021

Hiroshi Nakase et al.

Summary: The study aimed to develop specific treatment guidelines for patients with different types of Crohn's disease (CD), including luminal CD, CD with perianal disease or fistula, CD with small bowel stenosis, postoperative CD, and patients who need to reduce or discontinue treatment. The study reviewed relevant studies and utilized a modified Delphi process to reach consensus among specialists. The resulting statements provide guidance on treatment intensification and de-intensification for CD patients.

JOURNAL OF GASTROENTEROLOGY (2023)

Add to Collection

Review Gastroenterology & Hepatology

Psychological distress in inflammatory bowel disease

Paola Balestrieri et al.

Summary: Mental health disorders are common in inflammatory bowel disease (IBD) and have a significant impact on patients' quality of life and disease outcomes. However, psychiatric comorbidities receive less attention in routine care than physical symptoms. This review provides an overview of recent literature on the association between perceived stress and IBD outcomes, as well as the management of these patients.

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2023)

Add to Collection

Review Biochemistry & Molecular Biology

The Utility of Faecal Calprotectin, Lactoferrin and Other Faecal Biomarkers in Discriminating Endoscopic Activity in Crohn's Disease: A Systematic Review and Meta-Analysis

Anuj Bohra et al.

Summary: This meta-analysis evaluated the accuracy of faecal biomarkers in discriminating endoscopic activity and mucosal healing in Crohn's disease. The results showed that faecal calprotectin (FC) had high sensitivity and specificity in distinguishing active and inactive endoscopic disease, while faecal lactoferrin (FL) also had moderate accuracy in discriminating active disease. Further evaluation of novel faecal biomarkers is warranted.

BIOMEDICINES (2023)

Add to Collection

Review Gastroenterology & Hepatology

Quality of bowel preparation in patients with inflammatory bowel disease undergoing colonoscopy: What factors to consider?

Antonietta Gerarda Gravina et al.

Summary: An adequate bowel preparation is essential for successful colonoscopy in patients with inflammatory bowel disease (IBD) for various purposes. There are different formulations available, including high- and low-volume options based on polyethylene glycol. However, targeted studies on the quality of bowel preparation specifically in the IBD population are still needed, as current evidence is inconclusive. New frontiers are also exploring alternative methods using retrograde colonic lavage preparations.

WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY (2023)

Add to Collection

Review Gastroenterology & Hepatology

Review article: Translating STRIDE-II into clinical reality - Opportunities and challenges

Axel Dignass et al.

Summary: This article discusses the opportunities and challenges of a treat-to-target approach in inflammatory bowel disease (IBD) patients, with a focus on the current "Selecting Therapeutic Targets in Inflammatory Bowel Disease" (STRIDE-II) consensus. The study results show that STRIDE-II provides valuable guidance for personalized IBD management and reflects increased evidence of improved outcomes when more ambitious treatment goals, such as mucosal healing, are achieved.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Add to Collection

Article

The 2023 Impact of Inflammatory Bowel Disease in Canada: Mental Health and Inflammatory Bowel Disease

Lesley A Graff et al.

Journal of the Canadian Association of Gastroenterology (2023)

Add to Collection

Review Gastroenterology & Hepatology

Use of imaging modalities for decision-making in inflammatory bowel disease

Stephane Nancey et al.

Summary: Cross-sectional magnetic resonance enterography (MRE) and intestinal ultrasonography (IUS) are valuable and noninvasive imaging modalities for the assessment, monitoring, and prediction of disease activity and outcomes in inflammatory bowel disease (IBD) patients. However, the underutilization of IUS in clinical practice is due to the lack of validated indices and trained gastroenterologists and radiologists. Nevertheless, the increasing evidence highlights the importance of both IUS and MRE in aiding clinical decision-making.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2023)

Add to Collection

Article Gastroenterology & Hepatology

Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD

Benjamin Click et al.

Summary: This study describes the objective marker and TDM assessment in routine clinical practice prior to biologic therapeutic changes in adult IBD patients. The findings indicate that nearly one-third of patients undergoing a biologic dose change or discontinuation do not undergo objective disease activity assessment or TDM.

BMC GASTROENTEROLOGY (2022)

Add to Collection

Article Gastroenterology & Hepatology

Multinational evaluation of clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitis

Axel U. Dignass et al.

Summary: The current management approach for mild-to-moderate UC is primarily guided by patient perspectives and goals, alongside assessment of their medical and disease history. Important factors include educating patients about UC and its treatment, as well as understanding patient goals. Setting realistic short-term treatment targets is also a key consideration.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2022)

Add to Collection

Review Gastroenterology & Hepatology

Systematic review and meta-analysis: the advantage of endoscopic Mayo score 0 over 1 in patients with ulcerative colitis

Angelo Viscido et al.

Summary: Mucosal healing is a new target for the treatment of ulcerative colitis, and MES 0 is more strongly associated with a lower rate of clinical relapse compared to MES 1. MES 0 should be considered as the therapeutic target for patients with ulcerative colitis.

BMC GASTROENTEROLOGY (2022)

Add to Collection

Article Pharmacology & Pharmacy

The Lesson from the First Italian Lockdown: Impacts on Anxiety and Depressive Symptoms and Sleep Quality in Patients with Remission of Inflammatory Bowel Disease

Annamaria Spina et al.

Summary: This study aimed to evaluate the mental health status of patients with remission of inflammatory bowel disease during the lockdown in Italy. The results showed that female patients, patients with Crohn's disease, and individuals aged between 50 and 60 years experienced more severe anxiety, depression, and sleep quality issues.

REVIEWS ON RECENT CLINICAL TRIALS (2022)

Add to Collection

Article Gastroenterology & Hepatology

Adherence to Objective Therapeutic Monitoring and Outcomes in Patients with Inflammatory Bowel Disease with Adalimumab Treatment. A Real-world Prospective Study

Panu Wetwittayakhlang et al.

Summary: Objective monitoring and effective early treatment are crucial for improving therapeutic outcomes in IBD patients. This study assessed adherence to objective monitoring and its impact on clinical outcomes in IBD patients starting adalimumab therapy. The results showed that adherence to early objective monitoring with combined clinical and biomarkers assessment led to dose optimization and improved 1-year clinical remission rate in CD patients, but not in UC patients.

JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES (2022)

Add to Collection

Review Radiology, Nuclear Medicine & Medical Imaging

Treat to transmural healing: how to incorporate intestinal ultrasound into the treatment of inflammatory bowel disease

Aysha H. Al-Ani et al.

Summary: Intestinal ultrasound is a non-invasive imaging modality that can be used for the diagnosis and monitoring of inflammatory bowel disease. With appropriate training, it can be used as a bedside test to aid in treatment decisions and optimize patient care, with the potential to achieve healing of the intestine.

BRITISH JOURNAL OF RADIOLOGY (2022)

Add to Collection

Review Gastroenterology & Hepatology

Treat-to-target and sequencing therapies in Crohn's disease

Nicole M. Garcia et al.

Summary: This article discusses the factors to be considered in the treatment of Crohn's disease and emphasizes the importance of a treat-to-target strategy.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2022)

Add to Collection

Review Gastroenterology & Hepatology

Systematic Review: Gastrointestinal Ultrasound Scoring Indices for Inflammatory Bowel Disease

Thomas M. Goodsall et al.

Summary: The study systematically identified ultrasound scoring indices for assessing inflammatory bowel disease activity, with common components including bowel wall thickness, colour Doppler imaging, and bowel wall stratification. The correlation between ultrasound indices and reference standards, as well as sensitivity, specificity, accuracy, and other properties, varied within certain ranges. However, reliability and responsiveness data were limited, and most studies were rated with unclear or high risk of bias.

JOURNAL OF CROHNS & COLITIS (2021)

Add to Collection

Article Gastroenterology & Hepatology

Assessing adherence to objective disease monitoring and outcomes with adalimumab in a real-world IBD cohort

A. Al Khoury et al.

Summary: This study retrospectively reviewed the charts of 428 consecutive IBD patients and found that clinical and CRP testing were frequently conducted, but adherence to serial FCAL testing was low. Adherence to early follow-up visits resulted in earlier dose optimization and improved one-year clinical outcomes for patients.

DIGESTIVE AND LIVER DISEASE (2021)

Add to Collection

Article Gastroenterology & Hepatology

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

Dan Turner et al.

Summary: STRIDE-II presents treatment targets for both adult and pediatric IBD, including long-term and short-term goals. These targets cover aspects such as clinical response, endoscopic healing, quality of life, and growth, providing guidance for improving patient outcomes.

GASTROENTEROLOGY (2021)

Add to Collection

Review Gastroenterology & Hepatology

Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis

Brigida Barberio et al.

Summary: Patients with IBD have a high prevalence of anxiety and depression symptoms, with nearly one third affected by anxiety symptoms and a quarter affected by depression symptoms. Prevalence is even higher in patients with active disease, with half meeting criteria for anxiety symptoms and a third meeting criteria for depression symptoms.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)

Add to Collection

Review Psychiatry

Depression and Anxiety Disorders in Patients With Inflammatory Bowel Disease

Shurong Hu et al.

Summary: Mental health is an important aspect of care for IBD patients, with anxiety and depression being common psychological conditions. Screening and treating these mental disorders can lead to improved outcomes.

FRONTIERS IN PSYCHIATRY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Efficacy and tolerability of very low-volume bowel preparation in patients with inflammatory bowel diseases

Benedetto Neri et al.

Summary: The study evaluated the efficacy and tolerability of a very low-volume PEG-based solution in patients with IBD. Results showed that the VLV PEG-based bowel preparation was effective and well accepted by patients in this study, indicating it could be a preferred option for those who undergo periodic colonoscopies or individuals who have difficulty tolerating larger volumes of liquid.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2021)

Add to Collection

Review Gastroenterology & Hepatology

Burden of comorbid anxiety and depression in patients with inflammatory bowel disease: a systematic literature review

Marla C. Dubinsky et al.

Summary: Patients with inflammatory bowel disease often experience comorbid anxiety and depression, which can impact their quality of life and healthcare utilization. Non-pharmacologic interventions like cognitive behavioral therapy have shown to be effective in reducing rates of anxiety and depression in these patients. However, there are challenges in accessing mental-health services and addressing unmet clinical needs. Healthcare professionals should strive to improve care for IBD patients with anxiety or depression to optimize outcomes.

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2021)

Add to Collection

Article Psychiatry

Prevalence of depression and anxiety in people with inflammatory bowel disease and associated healthcare use: population-based cohort study

Peter Irving et al.

Summary: The study found that depression and anxiety are more common in people with IBD, leading to higher healthcare utilization and time off work. Therefore, people with IBD require specialized support and treatment for mental health issues.

EVIDENCE-BASED MENTAL HEALTH (2021)

Add to Collection

Article Gastroenterology & Hepatology

Acceptability of a 'treat to target' approach in inflammatory bowel disease to patients in clinical remission

Christian Selinger et al.

Summary: This study investigated the acceptability of a 'treat to target' approach in patients with inflammatory bowel disease (IBD) in clinical remission. The results showed that two-thirds of patients found this approach acceptable, with better adherence to current therapy being associated with acceptance of treat to target. Education and counseling materials may be needed to convince a substantial minority of patients about the importance of this approach.

FRONTLINE GASTROENTEROLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Proactive Infliximab Drug Monitoring Is Superior to Conventional Management in Inflammatory Bowel Disease

Samuel Raimundo Fernandes et al.

INFLAMMATORY BOWEL DISEASES (2020)

Add to Collection

Review Gastroenterology & Hepatology

Systematic Review and External Validation of Prediction Models Based on Symptoms and Biomarkers for Identifying Endoscopic Activity in Crohn's Disease

Eelco C. Brand et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

Add to Collection

Review Gastroenterology & Hepatology

Incremental Benefit of Achieving Endoscopic and Histologic Remission in Patients With Ulcerative Colitis: A Systematic Review and Meta-Analysis

Hyuk Yoon et al.

GASTROENTEROLOGY (2020)

Add to Collection

Review Gastroenterology & Hepatology

Treatment to target in patients with inflammatory bowel disease. What is the evidence?

Camilla Frimor et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2020)

Add to Collection

Review Psychology, Multidisciplinary

Non-pharmacological Interventions for Anxiety and Depression in Adults With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

Suja P. Davis et al.

FRONTIERS IN PSYCHOLOGY (2020)

Add to Collection

Review Gastroenterology & Hepatology

Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review

Jean-Frederic Colombel et al.

JOURNAL OF CROHNS & COLITIS (2020)

Add to Collection

Article Gastroenterology & Hepatology

Integrated Psychological Care is Needed, Welcomed and Effective in Ambulatory Inflammatory Bowel Disease Management: Evaluation of a New Initiative

Taryn Lores et al.

JOURNAL OF CROHNS & COLITIS (2019)

Add to Collection

Review Gastroenterology & Hepatology

Disease monitoring strategies in inflammatory bowel diseases: What do we mean by tight control?

Lorant Gonczi et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2019)

Add to Collection

Article Gastroenterology & Hepatology

IBDoc Canadian User Performance Evaluation

Alice C. Moore et al.

INFLAMMATORY BOWEL DISEASES (2019)

Add to Collection

Review Gastroenterology & Hepatology

A Treat-to-Target Update in Ulcerative Colitis: A Systematic Review

Ryan Ungaro et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)

Add to Collection

Review Gastroenterology & Hepatology

Targeting mucosal healing in Crohn's disease: what the clinician needs to know

Entcho Klenske et al.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2019)

Add to Collection

Article Gastroenterology & Hepatology

Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease

Geert D'Haens et al.

GASTROENTEROLOGY (2018)

Add to Collection

Review Gastroenterology & Hepatology

Ultrasound for Assessing Disease Activity in IBD Patients: A Systematic Review of Activity Scores

S. Bots et al.

JOURNAL OF CROHNS & COLITIS (2018)

Add to Collection

Article Gastroenterology & Hepatology

Comparative Accuracy of Bowel Ultrasound Versus Magnetic Resonance Enterography in Combination With Colonoscopy in Assessing Crohn's Disease and Guiding Clinical Decision-making

Mariangela Allocca et al.

JOURNAL OF CROHNS & COLITIS (2018)

Add to Collection

Article Gastroenterology & Hepatology

Limited uptake of ulcerative colitis treat-to-target recommendations in real-world practice

Robert V. Bryant et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

Management Strategies to Improve Outcomes of Patients With Inflammatory Bowel Diseases

Jean-Frederic Colombel et al.

GASTROENTEROLOGY (2017)

Add to Collection

Article Gastroenterology & Hepatology

Modifiable Risk Factors for Hospital Readmission Among Patients with Inflammatory Bowel Disease in a Nationwide Database

Edward L. Barnes et al.

INFLAMMATORY BOWEL DISEASES (2017)

Add to Collection

Article Gastroenterology & Hepatology

Therapeutic Drug Monitoring to Guide Infliximab Dose Adjustment is Associated with Better Endoscopic Outcomes than Clinical Decision Making Alone in Active Inflammatory Bowel Disease

Orlaith B. Kelly et al.

INFLAMMATORY BOWEL DISEASES (2017)

Add to Collection

Review Medicine, General & Internal

Crohn's disease

Joana Torres et al.

LANCET (2017)

Add to Collection

Article Medicine, General & Internal

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

Jean-Frederic Colombel et al.

LANCET (2017)

Add to Collection

Article Medicine, General & Internal

Novel treatment strategies in rheumatoid arthritis

Gerd R. Burmester et al.

LANCET (2017)

Add to Collection

Article Gastroenterology & Hepatology

Factors associated with the achievement of mucosal healing in Crohn's disease: the benefit of endoscopic monitoring in treating to target

Ren Mao et al.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2017)

Add to Collection

Review Gastroenterology & Hepatology

Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn's disease

S. C. Shah et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)

Add to Collection

Review Gastroenterology & Hepatology

IOIBD technical review on endoscopic indices for Crohn's disease clinical trials

L. Vuitton et al.

GUT (2016)

Add to Collection

Review Gastroenterology & Hepatology

Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis

Shailja C. Shah et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)

Add to Collection

Review Psychiatry

Depression and anxiety in patients with Inflammatory Bowel Disease: A systematic review

Rachel Neuendorf et al.

JOURNAL OF PSYCHOSOMATIC RESEARCH (2016)

Add to Collection

Article Gastroenterology & Hepatology

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

L. Peyrin-Biroulet et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)

Add to Collection

Article Gastroenterology & Hepatology

Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease

Niels Vande Casteele et al.

GASTROENTEROLOGY (2015)

Add to Collection

Article Gastroenterology & Hepatology

Converging Goals of Treatment of Inflammatory Bowel Disease From Clinical Trials and Practice

Barrett G. Levesque et al.

GASTROENTEROLOGY (2015)

Add to Collection

Article Gastroenterology & Hepatology

Risk Factors for Rehospitalization Within 90 Days in Patients with Inflammatory Bowel Disease

Jessica R. Allegretti et al.

INFLAMMATORY BOWEL DISEASES (2015)

Add to Collection

Review Multidisciplinary Sciences

Interventions to Improve Adherence in Patients with Immune-Mediated Inflammatory Disorders: A Systematic Review

Fanny Depont et al.

PLOS ONE (2015)

Add to Collection

Article Gastroenterology & Hepatology

Endoscopic Assessment and Treating to Target Increase the Likelihood of Mucosal Healing in Patients With Crohn's Disease

Guillaume Bouguen et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)

Add to Collection

Article Gastroenterology & Hepatology

Feasibility of Endoscopic Assessment and Treating to Target to Achieve Mucosal Healing in Ulcerative Colitis

Guillaume Bouguen et al.

INFLAMMATORY BOWEL DISEASES (2014)

Add to Collection

Review Gastroenterology & Hepatology

Clinical implications of ageing for the management of IBD

Christina Y. Ha et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)

Add to Collection

Article Gastroenterology & Hepatology

Validation of Endoscopic Activity Scores in Patients With Crohn's Disease Based on a Post Hoc Analysis of Data From SONIC

Marc Ferrante et al.

GASTROENTEROLOGY (2013)

Add to Collection

Article Gastroenterology & Hepatology

Therapeutic Drug Monitoring of Infliximab and Mucosal Healing in Inflammatory Bowel Disease: A Prospective Study

Stephane Paul et al.

INFLAMMATORY BOWEL DISEASES (2013)

Add to Collection

Article Gastroenterology & Hepatology

Mucosal healing at 3 months predicts long-term endoscopic remission in anti-TNF-treated luminal Crohn's disease

Clas-Goran Af Bjorkesten et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2013)

Add to Collection

Review Gastroenterology & Hepatology

Ulcerative colitis as a progressive disease: The forgotten evidence

Joana Torres et al.

INFLAMMATORY BOWEL DISEASES (2012)

Add to Collection

Review Gastroenterology & Hepatology

Inflammatory Bowel Disease of the Elderly: Frequently Asked Questions (FAQs)

Seymour Katz et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)

Add to Collection

Article Gastroenterology & Hepatology

Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis

Jean Frederic Colombel et al.

GASTROENTEROLOGY (2011)

Add to Collection

Article Gastroenterology & Hepatology

Endoscopic Monitoring of Infliximab Therapy in Crohn's Disease

Clas-Goran af Bjorkesten et al.

INFLAMMATORY BOWEL DISEASES (2011)

Add to Collection

Editorial Material Rheumatology

'Treat to target': moving targets from hypertension, hyperlipidaemia and diabetes to rheumatoid arthritis

Dan Atar et al.

ANNALS OF THE RHEUMATIC DISEASES (2010)

Add to Collection

Article Gastroenterology & Hepatology

Mucosal Healing Predicts Long-term Outcome of Maintenance Therapy with Infliximab in Crohn's Disease

Fabian Schnitzler et al.

INFLAMMATORY BOWEL DISEASES (2009)

Add to Collection

Article Gastroenterology & Hepatology

Mucosal healing in inflammatory bowel disease: Results from a Norwegian population-based cohort

Kathrine Frey Froslie et al.

GASTROENTEROLOGY (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.